Ecolab said reported net sales for Q1 2025 decreased 2% to $3,695.0 million, citing an unfavorable impact from the sale of the global surgical solutions business and currency translation. Organic sales increased 3%.

1. 01

   Ecolab said reported net sales for Q1 2025 decreased 2% to $3,695.0 million, citing an unfavorable impact from the sale of the global surgical solutions business and currency translation. Organic sales increased 3%.

2. 02

   The company said reported operating income for Q1 2025 increased 7% to $555.3 million. Net income attributable to Ecolab decreased 2% to $402.5 million, reported diluted EPS decreased 1% to $1.41, and adjusted diluted EPS increased 12% to $1.50.

3. 03

   Ecolab said cash provided by operating activities for Q1 2025 decreased $280 million compared to Q1 2024, citing an unfavorable change in working capital of $147 million and an unfavorable change in other liabilities of $138 million as key factors.

4. 04

   The company said it recorded restructuring charges of $39.4 million ($30.5 million after tax) related to the One Ecolab initiative in Q1 2025. It said it anticipates restructuring costs of $175 million by the end of 2027, and the related restructuring liability was $84.7 million as of March 31, 2025.

Key figures

Quarter ended March 31, 2025

Revenue

$3.7B

Operating income

$555M

Net income

$403M

EPS

$1.41

Operating cash flow

$369M

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.